What Happened?
Austin, TX-based Mirna Therapeutics has Appointed Jon Irvin as Chief Financial Officer
About the Company
Mirna Therapeutics, Inc. (Mirna) is a biotechnology research and development company focused on miRNA-directed oncology therapies. Featuring world-class research capabilities, a strong understanding of miRNA and cancer biology, and a broad IP portfolio, Mirna Therapeutics is well-positioned to capitalize on the emerging field of miRNA-based therapeutics.
About the Person
\r\n Jon Irvin has served as our Chief Financial Officer since November 2012, first as a Chief Financial Officer Consultant and then as a Mirna employee beginning in April 2013. Mr. Irvin was a Chief Financial Officer Consultant with Bridgepoint Consulting, LLC, a consulting firm providing financial consulting assistance to various organizations, including Mirna, from March 2012 to June 2013. Previously, Mr. Irvin served as the Chief Executive Officer and Vice President of Finance for Voxpath Networks, Inc., a telecommunications and intellectual property company and held various finance positions at Reddwerks Corporation, a software company, Esoterix, Inc., a medical labs company, Topaz Technologies, a pharmaceutical software company, and BioNumerik Pharmaceuticals, Inc., a pharmaceutical company. Mr. Irvin was previously an accountant with Price Waterhouse and Ernst & Young. Mr. Irvin received a bachelor`s degree in accounting from the University of Illinois.\r\n
Info Source
News
Short Profile